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INTRODUCTION
The nuclear envelope (NE) forms the boundary between
the nucleus and the cytoplasm and physically separates
transcription and translation. The nuclear lamina, together with
the inner (INM) and outer nuclear membranes (ONM) and the
nuclear pore complex are the major components of the NE. The
nuclear lamina is a flattened orthogonal network of filaments
lying subjacent to the INM. The filaments of the lamina are
composed of type V intermediate filament proteins termed
lamins. Like all intermediate filament proteins, lamins possess
a long central a -helical rod domain flanked by a short globular
N-terminal head and a long C-terminal tail domain. Lamins
apparently assemble into filaments through a series of
hierarchical associations. These include the initial formation of
dimers through parallel in register coiled-coil associations
through the rod domain, followed by anti-parallel half-
staggered lateral associations of dimers to form tetramers.
Tetramers then make head-to-tail longitudinal associations to
form protofilaments (see Goldberg et al., 1999; Stuurman et al.,
1998). 
The composition of the lamina varies according to cell type
and stage of differentiation. Two broad classes of lamins are
expressed in vertebrates and these are referred to as A-type
and B-type. These lamins vary in primary sequence and
biochemical properties as well as in their expression patterns.
B-type lamins are expressed in all germ cells and somatic cells
although different B-type lamins are expressed in each
(reviewed by Vaughan et al., 2000). Lamins B1 and B2 are the
major B-type lamins expressed in mammalian somatic cells
and these proteins are the products of separate genes (reviewed
by Gant and Wilson, 1997). Lamins A, C, C2 and A D 10
comprise the A-type lamins and all are alternatively spliced
products of a single gene. Lamin A and C are the most
abundant A-type lamins and differ in that lamin C lacks a 90
amino acid C-terminal extension possessed by lamin A but has
five unique amino acids at its C-terminus (reviewed by Quinlan
et al., 1995). Both lamin A and lamin C are expressed only in
differentiated cells and during mouse development appear at
the time of organogenesis (Rober et al., 1989); however, they
are dispensable for development since a lamin A/C knockout
mouse survives to adulthood (Sullivan et al., 1999). 
Recently, a number of different autosomal dominant
diseases have been shown to be caused by mutations in the
gene encoding lamins A and C (reviewed by Flier, 2000).
These diseases include an autosomal dominant form of Emery-
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Physical interactions between lamins and emerin were
investigated by co-immunoprecipitation of in vitro
translated proteins. Emerin interacted with in vitro
translated lamins A, B1 and C in co-immunprecipitation
reactions. Competition reactions revealed a clear
preference for interactions between emerin and lamin C.
Structural associations between lamins and emerin were
investigated in four human cell lines displaying abnormal
expression and/or localisation of lamins A and C. In each
cell line absence of lamins A and C from the nuclear
envelope (NE) was correlated with mis-localisation of
endogenous and exogenous emerin to the ER. In two cell
lines that did not express lamin A but did express lamin C,
lamin C as well as emerin was mis-localised. When GFP-
lamin A was expressed in SW13 cells (which normally
express only very low levels of endogenous lamin A and
mis-localise endogenous emerin and lamin C), all three
proteins became associated with the NE. When GFP-lamin
C was expressed in SW13 cells neither the endogenous nor
the exogenous lamin C was localised to the NE and emerin
remained in the ER. Finally, lamins A and C were
selectively eliminated from the NE of HeLa cells using a
dominant negative mutant of lamin B1. Elimination of these
lamins from the lamina led to the accumulation of emerin
as aggregates within the ER. Our data suggest that lamin
A is essential for anchorage of emerin to the inner nuclear
membrane and of lamin C to the lamina.
Key words: Lamins, Emerin, Nuclear envelope, Nuclear lamina,
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Dreifuss muscular dystrophy (AD EDMD) (Bonne et al., 1999;
Raffaele et al., 2000), dilated cardiomyopathy with conduction
system disease (Fatkin et al., 1999) and a Dunnigan-type
familial partial lipodystrophy (Shackleton et al., 2000; Cao and
Hegele, 2000). It is currently unclear why these very different
diseases arise through mutations in the same proteins.
However, since a majority of disease phenotypes are caused by
missense mutations that occur in different parts of the proteins
(Flier, 2000; Raffaele et al., 2000), one possibility is that these
lamins interact with a number of different nuclear proteins and
that different mutations affect different lamin interactions.
Emerin was first identified by positional cloning of a gene
on chromosome Xq28 that is mutated in individuals with X-
EDMD. The emerin gene encodes a 254 amino acid type II
integral membrane protein (Bione et al., 1994). Structural
analysis predicts that emerin contains a transmembrane region
at the C-terminus and a large hydrophilic N-terminal domain
with multiple putative phosphorylation sites (Bione et al.,
1994). In addition, emerin contains the LEM domain signature
common to a number of integral membrane proteins of the
inner nuclear membrane (reviewed by Hutchison et al., 2001).
Emerin is a serine rich protein that migrates as a 34 kDa band
on SDS-PAGE. It is principally located at the INM in almost
every tissue (Nagano et al., 1996: Manilal et al., 1996). In
cardiac muscle, emerin has also been located at intercalated
disks (Cartegni et al., 1997), although this finding was not
substantiated by later studies (Manilal et al., 1999). In skeletal
muscle cells grown in culture, a fraction of emerin is located
in the endoplasmic reticulum (ER) (Fairley et al., 1999). The
majority of lesions in the emerin gene that cause EDMD are
null mutations (Nagano et al., 1996, Manilal et al., 1997;
Manilal et al., 1998; Mora et al., 1997; Ellis et al., 1998; Yates
et al., 1999). However, some mutations result in the production
of modified forms of emerin (Manilal et al., 1997; Mora et al.,
1997; Ellis et al., 1998; Wulff et al., 1997; Yates et al., 1999).
These mutations occur throughout the protein with no obvious
hot-spots. Interestingly, some mutations in the N-terminal
‘nucleoplasmic’ domain cause mis-localisation of emerin
either to cytoplasmic membranes or to the nucleoplasm
(Fairley et al., 1999; Ellis et al., 1998). This finding is
consistent with the observation that sequences within the N-
terminal nucleoplasmic domain are necessary and sufficient to
target emerin to the INM (Östlund et al., 1999).
A possible link between X-EDMD and AD EDMD is that
A-type lamins form structural associations with emerin at the
INM. To test this hypothesis we have investigated lamin-
emerin interactions in vivo and in vitro. Our data suggest that
the organisation of both lamin C in the lamina and of emerin
at the INM is dependent upon lamin A. 
MATERIALS AND METHODS
Antibody reagents
Monoclonal antibodies against lamins A/C (JoL2 and JoL5), lamin A
(JoL4) and lamin B2 have been described previously (Dyer et al.,
1997). In addition, monoclonal antibodies against emerin (MANEM3
and MANEM5; Manilal et al., 1996) and LAP2 b (LAP17; Dechat et
al., 1998) have been described previously. The polyclonal rabbit
antibody against lamin C was raised to the last eight amino acids of
lamin C, including an N-terminal lysine as a linker (KHHVSGSRR).
The peptide was coupled to keyhole limpet haemocyanin through
primary amino groups using glutaraldehyde. The resulting protein-
peptide conjugate was dialysed overnight at 4°C against PBS. The
conjugate was then used to immunise a rabbit. Immune serum was
screened by indirect immunofluorescence and then affinity purified
against 10 mg of the lamin C peptide conjugated to CH Sepharose 4B
as described (Harlow and Lane, 1988). The antibody recognises the
lamin C-specific tail domain of recombinant lamin C, but no other
part of recombinant lamin C or any other recombinant lamins on
western blots. The antibody detects a single band migrating at 65 kDa
in western blots of nuclei isolated from HeLa, human dermal
fibroblasts and SW13 cells. In the majority of human cell lines and
primary human fibroblasts the antibody stains the NE exclusively (for
a complete characterisation of this antibody, see Venables et al., 2001).
Polyclonal anti-emerin was from J. Ellis (Ellis et al., 1998). The
anti-lamin B1 specific antibody was purchased from Santa Cruz
Biotechnology. Monoclonal anti-Ki67 was purchased from DAKO.
Expression and immunoprecipitation of recombinant
lamins, NUP-153 and emerin
Plasmid pWW1 hLamin B1 was constructed by subcloning an Nco1-
BamH1 fragment of human lamin B1 cDNA (Pollard et al., 1990) into
Nco1-BamH1 cut T7 expression vector pWW1 (Whitfield et al.,
1990). Cloning of cDNA encoding the first 188 amino acids of emerin
from total human skeletal muscle cDNA into the expression plasmid
pMW172, and full length emerin cDNA into plasmid pET17xb have
already been described (Manilal et al., 1996; Manilal et al., 1999).
Plasmids pET-1 hLamin A and pET-1 hLamin C are described
elsewhere (Moir et al., 1990; Moir et al., 1991). Nup-153 cDNA (gift
from Brian Burke, University of Calgary, Canada) was cloned into
pRSET-A using XhoI and PvuII. Recombinant lamins A, C, B1, Nup-
153, and the N-terminal 188 amino acids of emerin were expressed
using the TNTr Quick Coupled Transcription/Translation System
(Promega) under recommended conditions. Reticulolysates
containing expressed lamins and emerin were pooled and incubated
at 4°C overnight. Pefablocr, leupeptin, pepstatin and aprotinin
(Boehringer Mannheim) were added to a final concentration of 1 mM
each. Reaction mixtures were pre-cleared using paramagnetic
Dynabeadsr M-280 (DYNAL). Lamins A and C were recovered using
mAbs Jol2, JoL4 or Jol5 (or the lamin A-specific Jol4) conjugated to
Dynabeadsr according to a method previously described (Jenkins et
al., 1993). Likewise, emerin was immunoprecipitated using mAbs
MANEM3 and -5 (Manilal et al., 1996), and NUP-153 using mAb
414.
Cell culture and preparation of SW13/20
Human cervix carcinoma (HeLa) and Human adrenal cortex
carcinoma (SW13) cells (gift from H. Herrmann, Heidelberg) were
routinely maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (FCS, v/v) and 1%
penicillin/streptomycin (v/v) at 37°C in a humidified atmosphere
containing 5% CO2. Lymphoblastoid, lymphoma and lung carcinoma
cells were maintained in RPMI 1640 (GIBCO BRL) containing non-
essential amino acids, 15% FCS (v/v) and 1% penicillin/streptomycin.
SW13 cells were transfected with pCDNA-EGFP-HLA, a plasmid
containing human lamin A fused to EGFP (gift from L. Karnitz, Mayo
Clinic), using LipofectinTM (GIBCO BRL), 15 m g of DNA per
2.5· 105 cells and conditions recommended for Lipofectin
transfections. Stable clones were selected using 300 m g/ml G418
(Calbiochem). 
Cell fractionation
Cells were scraped from a 75 cm2 flask using a rubber policeman then
washed twice with phosphate-buffered saline (PBS) at 4°C. Cell lysis
occurred after incubation in cytoskeletal buffer (10 mM PIPES, pH
6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2 and 1 mM EGTA)
containing 0.5% Triton X-100 at 4°C for 5 minutes. Chromatin was
removed by digestion with 200 units/ml RNase-free DNase in
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digestion buffer (10 mM PIPES, pH 6.8, 300 mM sucrose, 50 mM
NaCl, 3 mM MgCl2, 1 mM EGTA, 5 units/ml RNase inhibitor
(Boehringer Mannheim) containing 0.5% Triton X-100 at 30°C for 30
minutes. Nuclei were washed with extraction buffer (10 mM PIPES,
pH 6.8, 250 mM ammonium sulphate, 300 mM sucrose, 3 mM MgCl2,
and 1 mM EGTA) twice for 5 minutes each time at 4°C. Nuclear
matrix fractions were solubilised in 8 M urea. Nuclei were pelleted
after each step by centrifugation at 1000 rpm for 5 minutes within a
pre-chilled microcentrifuge. Pefablocr (2 mM), leupeptin (10 m M),
pepstatin (1 m M), and aprotinin (0.5 m M) were included throughout. 
Construction and expression of GST/GFP fusion proteins
The construction of plasmid pGEX-XLaminB1 D 2+ is described
elsewhere (Ellis et al., 1997). This construct expresses amino acid
residues 34-420 from Xenopus lamin B1 as a GST fusion protein.
GST-XLaminB1D2 + fusion protein was expressed then purified from
Escherichia coli BL21 cells using a method described previously
(Ellis et al., 1997). The pEGFP-XLaminB1 D 2+ plasmid was
constructed by subcloning the SalI-NotI insert of pGEX-
XLaminB1D 2+ into pEGFP-C1 (Clontech) cut with SalI and
Bsp120L. Plasmid pEGFP-emerin was constructed by sub-cloning
full length emerin from pET17xb into pEGFP-C1 (Clontech) cut with
BamHI and HindIII. Plasmids pS65T-lamC and pS65T-lamA have
been described previously (Broers et al., 1997). HeLa and SW13 cells
grown on coverslips to 20% confluence were transfected with relevant
plasmids (1-2 m g/coverslip) using the calcium-phosphate method
(Graham and van der Eb, 1973). The cells were grown overnight and
media replaced, with expression allowed to proceed for a further 36-
48 hours.
Immunofluorescence microscopy
Lymphoblast/lymphoma cells were centrifuged onto coverslips at 300
rpm for 3 minutes prior to fixation. Cells grown on coverslips were
washed twice in PBS and fixed in ice-cold 1:1 (v/v) methanol-acetone
for 10 minutes. Nuclear matrices were prepared as described
elsewhere (Dyer et al., 1997). Coverslips were washed 3 times, with
0.5% newborn calf serum (NCS, v/v) in PBS. Hybridoma cell culture
supernatants (undiluted) containing mAbs Jol2, Jol4 and LN43 (gift
from Birgit Lane, Dundee) were used to stain nuclear lamins A/C, A
and B2 respectively. Likewise, supernatants of mAbs MANEM3 and
-5 were used to immunodetect emerin, and LAP17 (gift from Roland
Foisner, Vienna) to detect LAP 2 b. Goat anti-lamin B (Santa Cruz
Biotechnology) and rabbit anti-ER (gift from Daniel Louvard, Paris)
and anti-calreticulin (Calbiochem) were used at recommended
dilutions to stain lamin B1 and ER, respectively. Affinity purified
rabbit anti-lamin C was used at a dilution of 1/50, as described
previously (Venables et al., 2000). Primary antibodies were added for
1 hour at room temperature. Coverslips were washed three times with
PBS, then incubated with appropriate Rhodamine (TRITC)-
conjugated affinipure secondary antibodies (donkey anti-goat, goat
anti-mouse, and goat anti-rabbit; Jackson Immunoresearch) for a
further hour at room temperature. After several washes in PBS,
coverslips were mounted face down in Mowiol (Calbiochem)
containing 1 m g/ml DAPI. Immunostained samples were viewed using
a Zeiss axiovert 10 microscope with a plan-APOCHROMAT
63· /1.40-oil immersion lens and equipped with a Digital Pixel
Instruments 12-bit CCD camera. Images were captured using IP Lab
Scientific Imaging Software (Scanalytics). Additionally, a Zeiss LSM
410 confocal laser scanning microscope was used (63 · /1.40 oil
immersion lens) for imaging of emerin and ER within SW13 cells.
Gel electrophoresis and immunoblotting
Recombinant proteins and nuclear matrix fractions were resolved on
10% SDS-PAGE and transferred to nitrocellulose according to
established protocols (Jenkins et al., 1993). Nitrocellulose membranes
were washed with blocking buffer (5% milk powder (w/v), 0.1%
Tween-20 in PBS) for 1 hour at room temperature. Undiluted cell
culture supernatants containing mAbs Jol2, Jol4 and LN43 were used
to detect lamins A/C, A and B2, respectively. Goat anti-lamin B1
(Santa Cruz Biotechnology) was used at 1/200. Affinity purified rabbit
anti-lamin C was used at a dilution of 1/100. All primary antibodies
were incubated with membranes for 30 minutes at room temperature.
Membranes were rinsed with blocking buffer several times then
incubated with appropriate HRP-conjugated secondary antibodies
(rabbit anti-mouse, DAKO; goat anti-rabbit, BIO-RAD; donkey anti-
goat, Jackson Immunoresearch) for 30 minutes at room temperature.
ECL reagents (Amersham Life Science) were used for the
immunological detection of proteins after membranes were rinsed in
PBS. 
RESULTS
Lamin-emerin interactions in vitro
We initially investigated interactions between emerin and
lamins using co-immunoprecipitation assays in rabbit
reticulocyte lysates. Since interactions between emerin and
lamins have already been demonstrated (Fairley et al., 1999) we
established these assays as competition experiments in order to
determine the specificity of emerin-lamin complexes and the
relative strengths of emerin interactions with specific lamin
subtypes. Initially 35S-met-labelled lamins A, B1 and C, emerin
or the nuclear pore protein Nup153 were produced in rabbit
reticulocyte lysates. 35S-emerin and 35S-Nup153 were then
mixed, together with equal amounts of 35S-lamin A, 35S-lamin
B1 or 35S-lamin C (Fig. 1A). We have previously shown that in
vitro translated Nup153 interacts with lamins but not emerin.
Therefore Nup153 was used here as a control. Emerin was then
immunoprecipitated from each mixed lysate using an equal
mixture of the anti-emerin mAbs MANEM3 and MANEM5.
The immunoprecipitates were resolved on SDS-PAGE and
fluorography was performed in order to detect co-
immunoprecipitation of the other proteins. All three lamins co-
immunoprecipitated efficiently with emerin. However, although
Nup153 was present at the same concentration in each mixed
lysate, it was co-immunoprecipitated with emerin either at very
low levels or not at all (Fig. 1B). Thus we confirmed that
interactions between emerin and each lamin subtype occurred.
Morevoer, where lamins are capable of forming alternative
complexes (e.g. with Nup153), these were not present in
the MANEM3/5 immunoprecipitates. This may either be
because emerin-lamin interactions out-compete lamin-Nup153
interactions or because alternative complexes are excluded from
the immunoprecipitates. However, the absence of Nup153 from
the complex indicates that emerin forms a strong and exclusive
interaction with each lamin subtype in vitro. To investigate
whether emerin displayed a preference for any of the lamins,
competition experiments were established between individual
lamin polypeptides. In these experiments, 35S-emerin was
mixed with equal amounts of 35S-lamins A and C, 35S-lamins
A and B1 or 35S-lamins C and B1. Again emerin was
immunoprecipitated with MANEM3 and MANEM5 and
resolved on SDS-PAGE. The starting mixtures and the
immunoprecipitates are shown in Fig. 1C and D, respectively.
When emerin was mixed with lamins A and C, significantly
more lamin C compared with lamin A was recovered in
MANEM immunoprecipitates. When emerin was mixed with
lamins A and B1 similar amounts of each lamin was recovered
in MANEM immunoprecipitates (see Fig. 1E. Finally, when
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emerin was mixed with lamins B1 and C significantly more
lamin C was recovered than lamin B1. As a negative control,
each lamin and emerin was translated in isolation and
immunoprecipitated with MANEM3 and -5 in combination. As
expected, only emerin was found in immunoprecipitates (Fig.
1F). Since emerin appeared to display a preference for binding
to lamin C, densitometry was performed on fluorographs and
the intensity of each lamin band was compared with emerin
using UVIband software (UVItech Ltd). When lamin C was
present in immunoprecipitation reactions, it was recovered at
approximately 1:1 ratio with emerin (Table 1). The ratio of
lamin B to lamin C was ~1:3 (Fig. 1D; Table 1) when these two
lamins were co-immunoprecipitated with emerin. The ratio of
lamin A to lamin C was ~1:2 (Fig. 1D; Table 1) when these two
lamins were mixed with emerin. Finally, the ratio of lamin A to
lamin B was ~2:3 (Fig. 1D; Table 1) when these two lamins
were mixed with emerin. These data suggest that, although
emerin is able to interact with all three lamins in vitro, its
preferred interaction is with lamin C. 
Abnormal targeting of emerin in a cell line SW13
with altered expression and organisation of lamins
A and C
To investigate lamin-emerin interactions in vivo we compared
the distribution of emerin and the lamin B binding protein
LAP2b in two cell lines with very different lamin complements.
The expression of the different lamins in HeLa cells was
investigated by immunoblotting with specific antibodies against
lamins A/C, A, C, B1 and B2. All four lamins were expressed at
high levels (Fig. 2A). A similar investigation was performed on
the adrenal cortex carcinoma cell line SW13 (Paulin-Levasseur
et al., 1989). In this cell line lamin A was expressed at greatly
reduced levels (compared with HeLa) and was undetectable with
some antibodies (JoL4). By contrast, lamins B1 and B2 were
expressed at similar levels in SW13 and HeLa, whereas lamin C
was expressed at reduced but readily detectable levels (Fig. 2B).
Next, the distribution of lamins A and C were compared in HeLa
and SW13 cells by immunofluorescence. Using anti-lamin-C-
specific anti-sera, lamin C was detected predominantly in the
nuclear rim in HeLa cells (Fig. 2C). In SW13 cells lamin C was
detected at low levels in the nuclear rim but at high levels in the
nucleolus (Fig. 2D). (Note that the nucleolar distribution of
lamin C was confirmed by co-staining with Ki67 antibody and
in all subsequent experiments co-staining with Ki67 was used to
confirm nucleolar localisation of lamin C in the absence of lamin
A; data not shown.) Using the lamin-A-specific mAb JoL4,
lamin A was detected in nuclear speckles and at the nuclear rim
in HeLa cells but was undetectable in SW13 cells (Fig. 2C,D).
Lamins B1 and B2 were both localised exclusively at the nuclear
rim in HeLa and SW13 cells (data not shown). These data
suggested that, in SW13 cells, lamin A was expressed at very
low levels (compared with HeLa), whereas a significant fraction
of lamin C was mis-localised to the nucleolus.
Next we compared the distribution of LAP2b and emerin in
HeLa and SW13 cells. In each cell line, LAP2b was located at
the NE (Fig. 2E,F). In HeLa, emerin was detected as a distinct
nuclear rim stain indicating its location at the NE (Fig. 2E). By
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Fig. 1. Co-immunoprecipitation of in vitro translated lamins and
emerin. Human lamins A (lamA), B1 (lamB), C (lamC), human
Nup153 (Nup) and emerin were translated as 35S-met labelled
proteins in rabbit reticulocyte lysates. Lysates were mixed in the
following combinations to give approximately equal starting amounts
of radiolabelled protein: (A,B) Emerin+lamin C+Nup; emerin+lamin
A+Nup; emerin+lamin B+Nup. (C,D) Emerin+lamin C+lamin B;
emerin+lamin A+lamin B; emerin+lamin A+lamin C. (F) Lamin A,
lamin B1, lamin C and emerin translated separately and not mixed. E
shows a lower exposure of a lamin A+lamin B+emerin co-
immunoprecipitation. The area corresponding to the lamin A and
lamin B bands is presented. Two bands are clearly visible.
Immunoprecipitations were performed with MANEM3 and -5 in
combination (MANEM pull downs (A,C,E)). B and D show starting
mixtures. Immunoprecipitates or samples of starting lysates were
resolved on 8% SDS PAGE and fluorographed. § indicates the
position of lamin A; – indicates the position of lamin B; + indicates
the position of lamin C; = indicates the position of emerin; *
indicates the position of Nup153. 
Table 1. Densitometric analysis of fluorographs from
lamin and emerin co-immunoprecipitations*
Protein Ratio Ratio 
Experiment mixture % area lamin:emerin lamin:lamin
1 Emerin 0.419
Lamin C 0.393 1:1.1 1:2.1 (lamin A:C)
Lamin A 0.188 1:2.3
2 Emerin 0.433
Lamin C 0.416 1:1.04 1:2.85 (lamin B:C)
Lamin B 0.146 1:2.97
3 Emerin 0.388
Lamin B 0.354 1:1.1 1:1.37 (lamin A:B)
Lamin A 0.258 1:1.5
*Flourographs from lamin and emerin co-immunoprecipitation reactions
(Fig. 1) were scanned with a Kodak scanning densitometer using UVIband
software. The proportion of each band, as a percentage of the area of bands
within each single lane was determined. The ratio of % area of each lamin to
emerin and each lamin pair within a single experiment was calculated.
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contrast, in SW13 cells, emerin was located both at the NE and
within the cytoplasm. To investigate the site of emerin
localisation within the cytoplasm, SW13 cells were co-stained
with MANEM3 and antibodies against calreticulin. As a control,
SW13 cells were co-stained with MANEM3 and the
mitochondrial marker p32 (Matthews and Russell, 1998).
Confocal microscopy revealed that the cytoplasmic fraction of
emerin co-localised exclusively with calreticulin (Fig. 3) but did
not co-localise with p32 (data not shown). These data suggest that
in SW13 cells a significant fraction of emerin resides in the ER.
To further investigate the behaviour of emerin in HeLa and
SW13 cells, cDNA encoding full-length human emerin was
sub-cloned into pEGFP (pEGFP-emerin) and expressed in each
cell line following transient transfection. As expected, in HeLa
cells GFP-emerin was localised exclusively in the NE (Fig.
4E). When the same construct was transfected into SW13 cells
Fig. 2. Comparison of emerin
and lamin C distributions in
SW13 and HeLa cells. The
level of expression of different
lamins was compared in HeLa
(A) and SW13 cells (B) by
immunoblotting. Nuclei
isolated from 106 cells were
resolved on 10% SDS-PAGE,
transferred to nitrocellulose
and immunoblotted with mAbs
JoL2 (lamin A/C), JoL4 (lamin
A), LN43 (lamin B2), rabbit
polyclonal anti-lamin C or
goat anti-lamin B1 using a
multi-blot apparatus. The
distribution of lamin C (blocks
C and D), lamin A (blocks C
and D), emerin (blocks E and
F) and LAP2 b (blocks E and
F) in HeLa cells (blocks C and
E) and SW13 cells (blocks D
and F) were investigated by
indirect immunofluorescence
using polyclonal anti-lamin
C, JoL4, MANEM5 and
LAP17, respectively. In all
samples the distribution of
DNA was detected with DAPI.
Bars, 10 m m.
Fig. 3. Co-localisation of emerin and
calreticulin in SW13 cells. The
distribution of emerin (MANEM3)
was compared with the distribution of
calreticulin (ER) in SW13 cells by
indirect immunofluorescence and
confocal microscopy. The distribution
of DNA was detected using DAPI.
Bar, 10 m m.
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the majority of GFP-emerin was localised in the cytoplasm,
where it accumulated in large granular structures (Fig. 4A-D).
Co-staining with calreticulin revealed that although the
granular structures were distinct from the majority of the ER
they did contain ER proteins (Fig. 4D). Transfected cells were
also co-stained with specific antibodies against lamins C, B1
or B2. Surprisingly, a readily detectable fraction of lamin C
(Fig. 4A), but no lamin B1 (Fig. 4B) or B2 (Fig. 4C), relocated
from the nucleus to co-distribute with GFP-emerin in some of
the cytoplasmic granules.
A number of conclusions can be drawn from these data. First,
the absence of lamin A from the NE correlates with a significant
fraction of lamin C being mis-localised to the nucleolus and a
fraction of emerin residing in the ER. Second, when GFP-
emerin is overexpressed in SW13, it forms cytoplasmic
aggregates, probably within an ER sub-domain that traps some
lamin C but no lamins B1 or B2. Taken together, these data
suggest that emerin interacts with lamins A and/or C in vivo.
Emerin is localised in the ER in a range of cell lines
that display abnormal levels of expression and
distributions of lamins A and C
Birkitt’s lymphoma cell lines
A comparison of emerin and lamin C localisation in HeLa and
SW13 cell lines indicated that lamin A might organise both
proteins at the NE. To investigate the generality of this
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Fig. 4. GFP-emerin forms
aggregates within a sub-domain
of the ER in SW13 cells. GFP-
emerin was transiently
expressed in SW13 cells (rows
A-D) or HeLa cells (row E) and
its distribution was compared
with lamin C (row A), lamin B1
(row B), lamin B2 (row C) or
calreticulin (row D, ER) after
fixation. In each sample the
distribution of DNA was
revealed with DAPI. Images are
displayed as individual black
and white panels and as three-
colour merged images. In
merged images ‘yellow’
indicates spectral overlap
between red and green signals.
Arrowheads (row D) indicate
the position of emerin
aggregates within the ER. Bars,
10 m m.
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phenomenon we compared the distribution of emerin and
LAP2b in other human cell lines that are deficient for lamin A/C
expression or which display altered distributions of lamin C. A
Burkitt’s lymphoma cell line (Ramos) did not express lamin A
and expressed reduced levels of lamin C. Moreover, in
immunofluorescence experiments lamin C was localised
exclusively in the nucleolus. The levels of expression and
distribution of lamins B1 and B2 appeared normal (Table 2).
LAP2b was localised exclusively at the NE in Ramos cells. By
contrast, emerin was distributed exclusively in the ER (Table 2).
Small cell lung carcinomas
Previous investigations have shown that small cell lung
carcinomas express greatly reduced levels of lamins A and C
compared with non-small-cell lung carcinomas (Kaufman et
al., 1991). Therefore, we compared the distribution of LAP2 b
and emerin in non-small-cell and small cell lung carcinoma cell
lines. The non-small-cell lung carcinoma line used in this
investigation (NCl-H125) expressed high levels of lamins A,
C, B1 and B2 that were distributed mainly at the NE (Table 2).
In this cell line, LAP2b and emerin were both located
exclusively at the NE. In common with most examples (Broers
et al., 1993), the small cell lung carcinoma cell line used in the
study (NL-SCSC2) did not express lamin A or lamin C but
expressed high levels of lamins B1 and B2. LAP2 b was
localised at the NE in the small cell lung carcinoma, whereas
emerin was localised in the ER (Table 2).
EDMD cell lines
Finally, we compared emerin localisation in EBV-transformed
Fig. 5. The distribution of lamin C and emerin in lymphoblastoid cell lines. EBV-transformed lymphoblastoid cell lines were obtained from a
donor control (row A) and from an AD EDMD patient with a single point mutation giving rise to an amino acid substitution at position T528K
(row B). Each cell line was co-stained with rabbit anti-lamin C (Lamin C) and MANEM5 (emerin). The distribution of DNA in each sample
was detected with DAPI. Panels show individual black and white micrographs or three-colour merged images (merge) in which the distribution
of DAPI is shown in blue, lamin C in green and emerin in red/orange. In merged images, ‘yellow’ indicates spectral overlap between red and
green signals. Bar, 10 m m.
Table 2. Expression and distribution of lamin, LAP2b and emerin*
LamA LamA/C LamC LamB1 LamB2 LAP2 Emerin
Cell line Exp Dist Exp Dist Exp Dist Exp Dist Exp Dist Exp Dist Exp Dist
HeLa ++ rim ++ rim ++ rim ++ rim ++ rim ++ rim ++ rim
SW13 - NA + rim/no + rim/no ++ rim ++ rim ++ rim ++ ER
Ramos (Birkitt’s - NA + no + no ++ rim ++ rim ++ rim ++ ER
lymphoma)
NL-SCLC2 +/ - abs +/ - abs ND ++ rim ++ rim ++ rim ++ ER
NCl-H125 + to ++ rim + to ++ rim ND ++ rim ++ rim ++ rim ++ rim
LCL-control + rim + rim + rim ++ rim ++ rim ++ rim ++ rim+ER
LCL-AD + rim/abs + rim/abs + rim/abs ++ rim ++ rim ++ rim ++ rim/ER
EDMD
*JoL4 was used to detect lamin A (LamA); JoL2 was used to detect lamins A/C (LamA/C); rabbit anti-lamin C was used to detect lamin C (LamC); goat anti-
lamin B1 was used to detect lamin B1 (LamB1); LN43 was used to detect lamin B2 (LamB2); LAP17 was used to detect LAP2 b (LAP2); MANEM5 was used to
detect emerin. Dist, distribution detected by immunofluorescence; Exp, level of expression detected by western blotting; - , undetectable; +/- , very low levels of
expression; +, medium levels of expression; ++, high levels of expression; abs, absent; ER, staining in endoplasmic reticulum (where an ER distribution of emerin
was detected, this was confirmed by co-localisation with anti-calreticulin); NA, not applicable; ND, not done; no, nucleolar staining (where nucleolar staining of
lamin C was detected, this was confirmed by co-localisation with Ki67); rim, nuclear rim staining.
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lymphoblastoid cell lines (LCL) obtained from a control donor
and from a patient with autosomal dominant EDMD (AD
EDMD). The control LCL expressed relatively low levels of
lamins A and C but both were located in the nuclear rim (Table
2; Fig. 5A). Lamin B1 and B2 expression and distribution
(Table 2) in this cell line appeared normal. Although some
emerin was located in the ER (presumably as a consequence
of the relatively low-level expression of lamins A/C), the
majority was located at the NE (Fig. 5A). The AD EDMD cell
line was obtained from a patient having a missense mutation
in the lamin A/C tail (T528K). In this patient expression of
lamins A and C was variable, with some cells expressing
apparently normal levels of the proteins at the NE, whereas in
other cells both proteins were absent (Table 2; Fig. 5B). Again,
lamins B1 and B2 appeared normal both in terms of level of
expression and distribution (Table 2). The variable level of A-
type lamin expression in the AD EDMD patient permitted a
side-by-side comparison of emerin distribution in those cells
expressing lamins A/C and in those that do not. Cells in which
lamins A and C were expressed and localised at the NE (lamin
C is shown in Fig. 5B) also contained significant quantities of
emerin at the NE. By contrast, in adjacent cells that did not
express lamins A and C, emerin was located exclusively in the
ER/NE (Fig. 5B; the ER localisation was confirmed by co-
staining with anti-calreticulin (not shown)). Therefore, in a
range of cell lines, localisation of emerin at the NE correlates
with expression and localisation of lamins A and C at the NE.
In addition, lamin C localisation at the NE may also depend
upon lamin A.
Stable and transient expression of GFP-lamin A in
SW13 cells causes the relocalisation of lamin C and
emerin to the NE
Our immunofluorescence data have revealed a strong
correlation between abnormal expression and distribution of
lamins A and C and localisation of emerin in the ER. To
investigate whether this represented a causal relationship we
carried out transient and stable transfection experiments on
SW13 with GFP-lamins. Initially, we selected a number of cell
lines that had been stably transfected with GFP-lamin A.
One such cell line (SW13/20) is shown here, since it is
representative. Stable transfection with GFP-lamin A in SW13
resulted in levels of expression of the fusion protein that were
approximately fourfold higher than levels of expression of
lamin C (not shown). Importantly, all A-type lamins (including
endogenous lamin C) were located predominantly in the NE
rather than in the nucleolus (Fig. 6A). In SW13/20 cells
both LAP2 b (Fig. 6C) and emerin (Fig. 6B) were localised
exclusively at the NE. Next we performed transient
transfection experiments with GFP-lamins A, B1 and C.
Typically in these experiments 15% of cells expressed the
GFP-fusion protein. When SW13 was transfected with GFP-
lamin A, the GFP-fusion protein was localised at the NE
(Fig. 7A,B). Importantly, the endogenous lamin C became
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Fig. 6. The distribution of emerin and lamin C in SW13 cells stably transfected with GFP-lamin A (SW13/20). The distribution of lamin C,
emerin and LAP2b in SW13 cells was investigated by antibody staining using rabbit anti-lamin C (Lamin C, row A), MANEM5 (emerin, row
B) and LAP17 (LAP2, row C), respectively. In each case, antibody distribution was compared with the distribution of GFP-lamin A (GFP). The
distribution of DNA in each sample was detected with DAPI. Each panel displays individual black and white images and three-colour merged
images (merge) in which DAPI is displayed in blue, GFP-lamin A in green and antibody staining in red. In merged images ‘yellow’ indicates
spectral overlap between red and green signals. Bars, 10 m m. 
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predominantly co-localised with the GFP rather than in the
nucleolus (Fig. 7B). Emerin was also localised at the NE
in cells expressing GFP-lamin A but not in surrounding
untransfected cells (Fig. 7A, arrowhead; the arrow identifies a
mitotic cell lying adjacent to the cell expressing GFP-lamin A;
the cytoplasmic emerin observed next to the transfected cell is
within the mitotic cell). GFP-lamin B1 was also localised to the
NE in transfected SW13 cells but failed to cause the re-
localisation of endogenous lamin C or emerin to the NE (data
not shown). Finally, when SW13 was transfected with GFP-
lamin C, the fusion protein accumulated in nucleoplasmic
granules (Fig. 7C,D; note that when GFP-lamin C is transiently
expressed in HeLa cells it localises exclusively to the NE (data
not shown)). These granules did not influence the distribution
of endogenous lamins (endogenous lamin C remained in the
nucleolus; Fig. 7C) and emerin remained in the cytoplasm (Fig.
7D). As with previous experiments the nucleolar distribution
of lamin C and the ER localisation of emerin was confirmed
by co-localisation with Ki67 and calreticulin, respectively
(data not shown). These data strongly support the view that
localisation of emerin to the NE depends upon the presence of
lamins A and C within the lamina. Furthermore, the data also
suggest that the presence of lamin A within the lamina is
necessary (but possibly not sufficient) for lamin C localisation
to the NE.
Dominant negative mutants of lamin B1 selectively
eliminate lamins A and C from the lamina and cause
emerin to accumulate in cytoplasmic granules
To further investigate the relationship between emerin
localisation at the NE and the presence of lamins A and C in
the lamina, we used dominant negative mutants of lamin B1
to specifically disrupt A-type lamins. We have previously
described the creation of a dominant negative mutant of lamin
B1 that is capable of disrupting the lamina of sperm pronuclei
assembled in vitro (Ellis et al., 1997). This mutant protein
Fig. 7. Transient transfection of SW13 with GFP-lamin A, but not GFP-lamin C, rescues endogenous emerin and lamin C distributions. The
distribution of lamin C and emerin was investigated in SW13 cells following transient transfection with GFP-lamin A (rows A,B) or GFP-lamin
C (rows C,D). The distribution of endogenous lamin C and emerin was detected by immunofluorescence as described in Materials and
Methods. The distribution of DNA was detected with DAPI. In each panel the distributions of DNA, GFP or antibody staining are presented as
individual black and white images or as three-colour merged images in which antibody staining is shown in red, GFP-lamin A is shown in
green and DAPI is shown in blue. In merged images ‘yellow’ indicates spectral overlap between red and green signals. The arrows in A indicate
the position of a mitotic cell. Bars, 10 m m.
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(delta 2+) was fused to GFP and expressed in transient
transfection assays in HeLa cells. Following transfection, GFP-
delta 2+ accumulated as small nucleoplasmic granules that
formed over 48 hours (Fig. 8A-D). Both lamin A (Fig. 8A) and
lamin C (Fig. 8B) relocated from the nuclear lamina to the
nucleoplasmic granules over the same period of time. By
contrast, lamins B1 (Fig. 8C) and B2 (Fig. 8D) remained in the
nuclear lamina. To confirm that lamins B1 and B2 remained in
the nuclear lamina, transfected cells were extracted in situ with
detergents, nucleases and ammonium sulphate. Following this
procedure both B-type lamins were retained in the insoluble
lamina, demonstrating that their solubility properties were
unaffected by the presence of the mutant protein (data not
shown). Thus in these transfection experiments, GFP-delta 2+
exerted a dominant effect over A-type lamins, causing their
redistribution from the lamina to nucleoplasmic granules, but
had seemingly no effect on B-type lamins. Next we
investigated the effects of the dominant negative mutants on
emerin and LAP2b distribution. When HeLa cells were
transfected with GFP-delta 2+ and then stained with anti-
emerin antibodies, the majority of emerin was located in
cytoplasmic granules rather than the NE (Fig. 9A). By contrast,
LAP2b remained in the NE (Fig. 9B). 
The cytoplasmic granules observed in transfected HeLa
were unlike the ER distribution of emerin observed in lamin
A/C-deficient cell lines. Therefore, to investigate the location
of the cytoplasmic emerin, transfected cells were stained with
anti-calreticulin antibodies (TRITC) and anti-emerin
antibodies (Cy5). A typical result is shown (Fig. 10) and
reveals that emerin did not co-localise with the majority of
calreticulin in transfected cells. Instead. emerin was mainly
located in granules lying close to the NE. However, calreticulin
did accumulate within these granules (Fig. 10, arrowheads)
suggesting that the granules were within the ER. 
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Fig. 8. The effects of a dominant negative mutant of lamin B1 on lamin distribution in HeLa cells. A GFP-fusion of a dominant negative lamin
B1 mutant (GFP-Delta 2+) was transiently transfected into HeLa cells. The distribution of lamin A (row A), lamin C (row B), lamin B1 (row C)
and lamin B2 (row D) in transfected cells was compared with untransfected cells by antibody staining with JoL2, rabbit anti-lamin C, goat anti-
lamin B1 and LN43, respectively. The distribution of DNA was detected with DAPI. Each panel displays either individual black and white
images or three-colour merged images in which DAPI is shown in blue, GFP-Delta 2+ in green and antibody staining in red. Bar, 10 m m.
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DISCUSSION
Lamin C is the preferred in vitro binding partner of
emerin
The data presented here demonstrate that lamins A, C and B1
all interact with emerin in vitro. However, in competition
reactions the preferred interaction of in vitro translated emerin
is with lamin C. This finding, although novel, is consistent with
the results of previous investigations. In a recent study, Östlund
et al. (1999) reported that the nucleoplasmic domain of emerin
is both necessary and sufficient for targeting integral
membrane proteins of the ER to the INM. We have shown that
this domain of emerin binds to lamins following translation of
both proteins in rabbit reticulocyte lysates. Emerin also co-
immunoprecipitates from C2C12 myoblast lysates in a
complex containing lamins A, C and B1, as well as actin
(Fairley et al., 1999). It is not clear which protein (or proteins)
within this complex emerin was associating with, since A-type
lamins form hetero-oligomeric complexes with B-type lamins
in cell lysates (Dyer et al., 1999) and actin also binds to lamin
A in vitro (Sasseville et al., 1998). Therefore, it is possible that,
in cell lysates, the complex containing emerin, lamin B1, lamin
C and actin is formed through association of all three proteins
with lamin A. Direct interactions between the nucleoplasmic
domain of emerin and lamin A have been detected using the
BIAcore biosensor (Clements et al., 2000). Based on the data
presented here and previously published evidence we conclude
that emerin probably associates with residues conserved
between A-type and B-type lamins, possibly as a multimer
(Clements et al., 2000), but that its preferred association is with
lamin C.
Evidence for a hierarchy of lamina associations
mediated by lamin A
We investigated emerin localisation in two different human cell
lines that were deficient for synthesis of lamins A and C and
Fig. 9. The influence of GFP-Delta 2+ on the distribution of emerin and LAP2 b in HeLa cells. HeLa cells were transiently transfected with
GFP-delta 2+ and the distributions of emerin (row A) and LAP2 b (row B) were compared in transfected and untransfected cells by
immunofluorescence using MANEM5 (emerin) and LAP17 (LAP2). The distribution of DNA was detected with DAPI. Panel displays
individual black and white micrographs or three-colour merged images in which DAPI is shown in blue, GFP-Delta 2+ in green and antibody
staining in red. In merged images ‘yellow’ indicates spectral overlap between red and green images. Bar, 10 m m.
Fig. 10. Emerin is located in
aggregates within the ER in
HeLa cells transfected with
GFP-delta 2+. The distribution
of emerin was compared with
the distribution of calreticulin
in cells that were transiently
transfected with GFP-delta 2+
by four-channel fluorescence.
Transfected cells were stained
with DAPI to reveal the distribution of DNA; with MANEM5 (Cy5)
to reveal the distribution of emerin; and with rabbit anti-calreticulin
(TRITC) to reveal the distribution of calreticulin within the ER.
Images are displayed either as individual black and white panels or a
four-colour merged image in which DAPI is displayed in blue, GFP-
delta 2+ in green, calreticulin in red, and emerin in white. It should
be noted that when calreticulin staining was omitted no bleed
through between the Cy5 and the TRITC filters was observed. Bars,
10 m m.
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two further cell lines that were deficient for lamin A synthesis
and in which lamin C was mis-localised to the nucleolus. In
each cell line either all or a majority of emerin was mis-
localised to the ER. In addition, we used a dominant negative
mutant of lamin B1 that selectively eliminates lamins A and C
but not lamins B1 and B2 from the NE of HeLa cells. A
consequence of eliminating lamins A and C from the NE was
that emerin relocated from the NE to the ER, where it formed
insoluble inclusions. 
Our data suggest that lamin A has a central role in tethering
both emerin and lamin C to the NE. The following evidence
supports this model. Association of lamin C with the NE in
two of the cell lines reported here is dependent upon the
presence of lamin A, and in its absence lamin C organisation
is disrupted such that most (SW13) or all (Ramos) is mis-
localised to the nucleolus. In SW13 cells the failure of lamin
C to be incorporated into the lamina is a direct consequence of
the absence of lamin A since transient or stable expression
GFP-lamin A causes significant re-localisation of endogenous
lamin C to the NE. The failure of lamin C to be incorporated
into the lamina in the absence of lamin A may result from weak
associations between lamin C and lamin B filaments or because
lamin C is not isoprenylated and carboxy methylated and
cannot accumulate at the NE on its own. Thus lamin A may be
required to carry lamin C to the NE or to mediate its association
with lamina filaments or both. It is unclear why, in the absence
of lamin A, lamin C becomes mis-localised to the nucleolus.
However, it is possible that the nucleolus is a default location
for some proteins that might otherwise form damaging
structures (e.g. aggregates) when they are unable to accumulate
at their normal sites of assembly.
Evidence that lamin C incorporation into the lamina is
dependent on the presence of lamin A has been reported
previously. When fluorescently labelled lamin C was
microinjected into Swiss 3T3 cells it forms small aggregates
in the nucleoplasm which persist for several hours (an
analogous situation was observed in this study when GFP-
lamin C was transiently expressed in SW13 cells). When lamin
A and lamin C were injected together into Swiss 3T3 cells they
are both incorporated into the NE rapidly (Pugh et al., 1997).
In agreement with these findings, when lamin C was
transfected into cells arrested in S-phase it remained in the
nucleoplasm, whereas lamin A was incorporated into the NE
under similar conditions. However, if the transfected cells were
released from S-phase and permitted to divide, presumably
allowing transfected lamin C to interact with soluble lamin A,
the lamin C became incorporated into the NE during the
following G1 phase (Horton et al., 1992). 
We observed that emerin is mis-localised to the ER in four
different human cell lines that display abnormal expression or
localisation of lamins A and C. Moreover, expression of GFP-
lamin A in one of these lines resulted in relocation of emerin
from the ER to the NE. In all cell lines employed in the study,
lamins B1 and B2 were expressed and localised normally and
LAP2b was localised at the NE. Thus, even though emerin can
bind to lamin B1 in vitro, the presence of this protein in the
lamina is not sufficient to anchor emerin at the INM. Instead
these data suggest that the presence of lamins A and C at the
NE is necessary for emerin localisation at the INM. The data
reported here is entirely consistent with the recent description
of the lamin A/C-knockout mouse. In lamin A/C - /- mice,
emerin is located mainly in the ER in most tissues (Sullivan et
al., 1999). Consistent with this data, when we used dominant
negative mutants of lamin B1 to selectively eliminate lamins A
and C from the NE in HeLa cells, emerin relocated from the
INM to inclusions within the ER. 
Our data can be explained by a hierarchical series of
associations between lamin A, lamin C and emerin. In this
hierarchy, lamin A may mediate the association of lamin C
with the lamina and, once present, lamin C may stabilise the
association of emerin with the INM. In previous studies
associations between lamins A/C and emerin have been
reported but the possibility that lamin A and lamin C perform
different functions at the INM were not considered. For
example, a clear temporal correlation between emerin and
lamin A/C association with the reforming NE at telophase has
been reported (Manilal et al., 1999). Similar temporal
correlations were reported in live GFP-imaging studies
(Haraguchi et al., 2000). In addition, one study reported a
striking spatial correlation in which lamins A/C and emerin co-
associate with the reforming NE in discrete foci at telophase,
whereas lamin B1 and LAP2 b re-associates throughout the NE
(Dabauvalle et al., 1999). This spatial correlation between
lamin A/C and emerin incorporation at the reforming NE is all
the more striking because A-type lamins do not return to the
nucleus until after the formation of a transport-competent
envelope, whereas emerin-containing membranes associate
with chromatin much earlier. Although all three studies
indicated a structural complex involving emerin, lamin A and
lamin C at the INM, none of the studies was able to distinguish
between different roles for lamin A and lamin C in the
complex. Five observations led us to present a new hypothesis
to explain lamin-emerin associations at the INM. (1) emerin’s
preferred in vitro binding partner is lamin C. (2) Emerin is
never present in the NE in the absence of lamin C. (3) Lamin
C is not incorporated into the lamina in the absence of lamin
A. (4) Lamin C can be sequestered into emerin aggregates in
the ER when GFP-emerin is overexpressed in lamin A-
deficient cells. (5) We have demonstrated previously that lamin
A is incorporated into the lamina through association with
lamin B filaments (Dyer et al., 1999). Therefore, we propose
that the hierarchy of lamina associations involving emerin is as
follows: lamin A associates with lamin C as either dimers or
tetramers in the nucleoplasm. Lamin A/C then associates with
B-type lamina filaments, this association being mediated by
lamin A. The association of lamin A with the lamina allows
incorporation of lamin C but in the absence of lamin A, lamin
C accumulates at default sites in the nucleus. Once
incorporated into the lamina, lamin C associates with emerin
at the INM. The association between emerin and lamin C may
stabilise and tether both proteins at the lamina. Thus in the
absence of lamin C, emerin is not stably associated with the
lamina and we speculate that, in the absence of emerin, lamin
C may not be stably associated with the INM. This model
provides an explanation for the accumulation of lamin C in
cytoplasmic aggregates when GFP-emerin was overexpressed
in SW13 cells. Presumably, in this instance, emerin aggregates
were a preferred location compared with the default location
in nucleoli.
Our data suggest that emerin can bind to lamin B1 in vitro.
However, we found no evidence to suggest that B-type lamins
influences emerin behaviour in vivo. B-type lamins have a
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number of specific binding partners at the NE, including
LAP2b and LBR (reviewed by Vaughan et al., 2000). It is
possible that potential emerin binding sites on B-type lamins,
organised as lamina filaments, are unavailable because they are
occupied by other INM proteins with higher binding affinities.
Thus, although emerin can associate with B-type lamins, it
does not do so in living cells.
Disease causing mutations in the lamin A/C gene
and their relationship to lamina structure
Since the report early last year that mutations in the gene
encoding lamins A and C cause AD-EDMD, it has become clear
that a large range of lamin A/C mutations give rise to a number
of diseases (Bonne et al., 1999: Brodksy et al., 2000; Cao et al.,
2000; Fatkin et al., 1999; Raffaele et al., 2000). The mutations
so far identified map to different regions of the lamin A/C protein
depending upon the disease. Missense mutations causing EDMD
map either to highly conserved residues in the lamin A/C tail
(Bonne et al., 1999; Raffaele et al., 2000), or to equally highly
conserved residues throughout the coiled-coil domain (Raffaele
et al., 2000). The spread of mutations causing AD-EDMD
suggest that lamin A/C makes a number of molecular
interactions at the INM and that different mutations disrupt
different interactions. Reported interactions are with emerin
(present study; Fairley et al., 1999; Clements et al., 2000), lamin
B (present study; Dyer et al., 1999), lamin A to lamin C (present
study; Pugh et al., 1997), the chromatin binding protein LAP2a
(Dechat et al., 2000), LAP1C (Powell and Burke, 1990), the
tumour suppressor protein p110RB (Ozaki et al., 1994) and
chromatin (Höger et al., 1991; Glass et al., 1993). If the model
presented above is correct, mutations in lamin A/C and perhaps
in emerin might give rise to loss or weakened association of
lamin C with the lamina in EDMD. This in turn would lead to
the possibility of abnormal lamin C complexes forming
elsewhere in the nucleus (e.g. the nucleolus). Indeed, in a
preliminary investigation of LCLs from 20 EDMD patients,
abnormal nucleoplasmic distributions of lamin C were observed
in a majority of cases (E. Wang, M.W. and C.J.H., unpublished).
Given the range of associations reported for A-type lamins,
abnormal nuclear localisation of lamin C may result in
significant and deleterious gain of function. Therefore, abnormal
nuclear distributions of lamin C rather than an absence of emerin
from the INM may promote EDMD and other lamin diseases.
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